Browsing: Oligometastatic

Top Line: How do we safely integrate SBRT into targeted therapy or immunotherapy regimens for oligometastatic cancer?The Study: Over the…

Top Line: SC.24 showed that spine SBRT (24 Gy in 2 fractions) improves pain control and local control compared to…

Headline: Metastasis-directed radiation prolongs time off androgen deprivation therapy (ADT). The Study: We love this one, and your patients with…

As opposed to most available data on recurrent oligomets, this retrospective look at outcomes following radiation to all sites of…

Top Line: Can safe and effective SABR for oligometastatic cancer be translated to a regional cancer network? The Study: The…

Headline: Oligometastatic breast cancer does not appear to benefit from metastasis directed therapy. The Study: The randomized EA2108 trial found…

Top Line: What’s better than long-term outcomes from SABR-COMET? The Study: Longer-term outcomes. Again, this phase 2 trial included 99…

Top Line: Local treatment of the primary tumor site in the setting of distant disease has known advantages for cancers…